Acadia Pharmaceuticals Files 2024 10-K
Ticker: ACAD · Form: 10-K · Filed: Feb 27, 2025 · CIK: 1070494
| Field | Detail |
|---|---|
| Company | Acadia Pharmaceuticals Inc (ACAD) |
| Form Type | 10-K |
| Filed Date | Feb 27, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
TL;DR
Acadia dropped its 2024 10-K. Full financials and biz details inside.
AI Summary
Acadia Pharmaceuticals Inc. filed its 2024 10-K on February 27, 2025, reporting on its fiscal year ending December 31, 2024. The company, based in San Diego, CA, operates in the pharmaceutical preparations sector. Key financial data and operational details for the fiscal year 2024 are presented in this comprehensive annual report.
Why It Matters
This filing provides investors and stakeholders with a detailed overview of Acadia's financial performance, strategic initiatives, and risk factors for the fiscal year 2024, crucial for understanding the company's current standing and future outlook.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Acadia faces inherent risks related to drug development, regulatory approvals, market competition, and patent expirations.
Key Numbers
- 1231 — Fiscal Year End (The report covers the fiscal year ending on this date.)
- 20250227 — Filing Date (The date the 10-K was officially submitted to the SEC.)
Key Players & Entities
- ACADIA PHARMACEUTICALS INC (company) — Filer
- 2024-12-31 (date) — Fiscal Year End
- 2025-02-27 (date) — Filing Date
- SAN DIEGO, CA (location) — Business Address
FAQ
What is Acadia Pharmaceuticals Inc.'s primary business sector?
Acadia Pharmaceuticals Inc. operates in the Pharmaceutical Preparations sector, with the Standard Industrial Classification code [2834].
When did Acadia Pharmaceuticals Inc. file its 2024 10-K report?
The 10-K report for the fiscal year ending December 31, 2024, was filed on February 27, 2025.
Where is Acadia Pharmaceuticals Inc. headquartered?
Acadia Pharmaceuticals Inc.'s business and mailing address is 12830 El Camino Real, Suite 400, San Diego, CA 92130.
What is the SEC file number for Acadia Pharmaceuticals Inc.'s 10-K filing?
The SEC file number for this 10-K filing is 000-50768.
What is the Central Index Key (CIK) for Acadia Pharmaceuticals Inc.?
The Central Index Key (CIK) for Acadia Pharmaceuticals Inc. is 0001070494.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on February 27, 2025 regarding ACADIA PHARMACEUTICALS INC (ACAD).